Evaluating the Long Term Immunogenicity of Ebola Virus Vaccines Ad26-ZEBOV and MVA-BN-Filo
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2017
At a glance
- Drugs Ad26 EBOV vaccine (Primary) ; Modified Vaccinia Ankara Bavarian Nordic Ebola Marburg vaccine (Primary)
- Indications Ebola virus infections
- Focus Pharmacodynamics
- Acronyms PRISM
- 22 Nov 2017 Planned primary completion date changed from 31 Oct 2017 to 31 Oct 2018.
- 17 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 08 May 2017 New trial record